- Home
- PULM vs NMTC Comparison
PULM vs NMTC Comparison
Compare PULM & NMTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- NMTC
- Stock Information
- Founded
- PULM 2003
- NMTC 2009
- Country
- PULM United States
- NMTC United States
- Employees
- PULM N/A
- NMTC N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- NMTC Medical/Dental Instruments
- Sector
- PULM Health Care
- NMTC Health Care
- Exchange
- PULM Nasdaq
- NMTC Nasdaq
- Market Cap
- PULM 28.3M
- NMTC 30.9M
- IPO Year
- PULM N/A
- NMTC N/A
- Fundamental
- Price
- PULM $8.90
- NMTC $0.58
- Analyst Decision
- PULM
- NMTC Strong Buy
- Analyst Count
- PULM 0
- NMTC 1
- Target Price
- PULM N/A
- NMTC $1.45
- AVG Volume (30 Days)
- PULM 20.6K
- NMTC 269.2K
- Earning Date
- PULM 05-15-2025
- NMTC 05-13-2025
- Dividend Yield
- PULM N/A
- NMTC N/A
- EPS Growth
- PULM N/A
- NMTC N/A
- EPS
- PULM N/A
- NMTC N/A
- Revenue
- PULM $1,921,000.00
- NMTC $5,758,777.00
- Revenue This Year
- PULM N/A
- NMTC $292.88
- Revenue Next Year
- PULM $134.88
- NMTC N/A
- P/E Ratio
- PULM N/A
- NMTC N/A
- Revenue Growth
- PULM N/A
- NMTC 54.53
- 52 Week Low
- PULM $1.78
- NMTC $0.40
- 52 Week High
- PULM $10.40
- NMTC $1.39
- Technical
- Relative Strength Index (RSI)
- PULM 69.72
- NMTC 36.93
- Support Level
- PULM $7.94
- NMTC $0.59
- Resistance Level
- PULM $9.37
- NMTC $0.66
- Average True Range (ATR)
- PULM 0.66
- NMTC 0.04
- MACD
- PULM 0.30
- NMTC -0.00
- Stochastic Oscillator
- PULM 88.69
- NMTC 7.39
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About NMTC NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.